{"id":"https://openalex.org/W2011765548","doi":"https://doi.org/10.1002/path.4052","title":"Differential drug class\u2010specific metastatic effects following treatment with a panel of angiogenesis inhibitors","display_name":"Differential drug class\u2010specific metastatic effects following treatment with a panel of angiogenesis inhibitors","alternate_titles":[],"publication_year":2012,"publication_date":"2012-07-03","ids":{"openalex":"https://openalex.org/W2011765548","doi":"https://doi.org/10.1002/path.4052","mag":"2011765548","pmid":"https://pubmed.ncbi.nlm.nih.gov/22611017"},"language":"en","primary_location":{"id":"doi:10.1002/path.4052","doi":"https://doi.org/10.1002/path.4052","is_oa":false,"landing_page_url":"https://doi.org/10.1002/path.4052","pdf_url":null,"source":{"id":"https://openalex.org/S4394736614","display_name":"The Journal of Pathology","issn_l":"0022-3417","issn":["0022-3417","1096-9896"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pathology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2011765548"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5039751498","display_name":"Alicia S. Chung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alicia S Chung","raw_affiliation_strings":["Genentech Inc, South San Francisco, CA 94080, USA","Genentech Inc., South San Francisco, CA, USA","These authors contributed equally to this study"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc, South San Francisco, CA 94080, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"These authors contributed equally to this study","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5001204975","display_name":"Marcin Kowanetz","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Marcin Kowanetz","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA, USA","These authors contributed equally to this study"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]},{"raw_affiliation_string":"These authors contributed equally to this study","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061452083","display_name":"Xiumin Wu","orcid":"https://orcid.org/0009-0002-7134-3206","observed_orcids":["https://orcid.org/0009-0002-7134-3206"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Xiumin Wu","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085218636","display_name":"Guanglei Zhuang","orcid":"https://orcid.org/0000-0001-8141-5096","observed_orcids":["https://orcid.org/0000-0001-8141-5096"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Guanglei Zhuang","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032297030","display_name":"Hai Ngu","orcid":"https://orcid.org/0000-0003-4948-6307","observed_orcids":["https://orcid.org/0000-0003-4948-6307"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Hai Ngu","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071970648","display_name":"David Finkle","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"David Finkle","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5087736818","display_name":"L\u00e1szl\u00f3 G. K\u00f6m\u00fcves","orcid":"https://orcid.org/0000-0003-3057-4382","observed_orcids":["https://orcid.org/0000-0003-3057-4382"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Laszlo Komuves","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068641693","display_name":"Franklin V. Peale Jr.","orcid":"https://orcid.org/0000-0002-8581-2942","observed_orcids":["https://orcid.org/0000-0002-8581-2942"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Franklin Peale","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5101652233","display_name":"Napoleone Ferrara","orcid":"https://orcid.org/0000-0002-7029-6375","observed_orcids":["https://orcid.org/0000-0002-7029-6375"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"Napoleone Ferrara","raw_affiliation_strings":["Genentech Inc., South San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Genentech Inc., South San Francisco, CA, USA","institution_ids":["https://openalex.org/I183934855"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5101652233"],"corresponding_institution_ids":["https://openalex.org/I183934855"],"apc_list":{"value":5450,"currency":"USD","value_usd":5450},"apc_paid":null,"fwci":4.3285,"has_fulltext":false,"cited_by_count":91,"citation_normalized_percentile":{"value":0.96193958,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":100},"biblio":{"volume":"227","issue":"4","first_page":"404","last_page":"416"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10422","display_name":"Angiogenesis and VEGF in Cancer","score":1.0,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11469","display_name":"Lymphatic System and Diseases","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10336","display_name":"Cancer Cells and Metastasis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/angiogenesis-inhibitors","display_name":"angiogenesis inhibitors","score":0.8550000190734863},{"id":"https://openalex.org/keywords/sunitinib","display_name":"sunitinib","score":0.8370000123977661},{"id":"https://openalex.org/keywords/metastasis","display_name":"metastasis","score":0.6489999890327454},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.5600000023841858},{"id":"https://openalex.org/keywords/endothelial-barrier-function","display_name":"endothelial barrier function","score":0.7279999852180481},{"id":"https://openalex.org/keywords/pulmonary-vascular-permeability","display_name":"pulmonary vascular permeability","score":0.9179999828338623},{"id":"https://openalex.org/keywords/tyrosine-phosphorylation","display_name":"tyrosine phosphorylation","score":0.8309999704360962},{"id":"https://openalex.org/keywords/endothelial-junctions","display_name":"endothelial junctions","score":0.9549999833106995},{"id":"https://openalex.org/keywords/anti-vegf-antibody","display_name":"anti-VEGF antibody","score":0.7310000061988831},{"id":"https://openalex.org/keywords/receptor-tyrosine-kinase-inhibitors","display_name":"receptor tyrosine kinase inhibitors","score":0.8949999809265137},{"id":"https://openalex.org/keywords/dose-dependent-side-effects","display_name":"dose-dependent side effects","score":0.6909999847412109}],"concepts":[{"id":"https://openalex.org/C2779490328","wikidata":"https://www.wikidata.org/wiki/Q417542","display_name":"Sunitinib","level":3,"score":0.8374719619750977},{"id":"https://openalex.org/C2779013556","wikidata":"https://www.wikidata.org/wiki/Q181876","display_name":"Metastasis","level":3,"score":0.7009697556495667},{"id":"https://openalex.org/C2780394083","wikidata":"https://www.wikidata.org/wiki/Q539568","display_name":"Angiogenesis","level":2,"score":0.6354166269302368},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6173648238182068},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4775053858757019},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.4616381824016571},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.44028523564338684},{"id":"https://openalex.org/C113045295","wikidata":"https://www.wikidata.org/wiki/Q7916465","display_name":"Vascular permeability","level":2,"score":0.43071597814559937},{"id":"https://openalex.org/C2777025900","wikidata":"https://www.wikidata.org/wiki/Q29725","display_name":"Vascular endothelial growth factor","level":3,"score":0.4207260310649872},{"id":"https://openalex.org/C101544691","wikidata":"https://www.wikidata.org/wiki/Q420511","display_name":"Receptor tyrosine kinase","level":3,"score":0.4157172441482544},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.39224886894226074},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.341320663690567},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2735152840614319},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.2635701596736908},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.17432886362075806},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.1656436026096344},{"id":"https://openalex.org/C167734588","wikidata":"https://www.wikidata.org/wiki/Q4356503","display_name":"VEGF receptors","level":2,"score":0.10182845592498779}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077157","descriptor_name":"Sorafenib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077210","descriptor_name":"Sunitinib","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000911","descriptor_name":"Antibodies, Monoclonal","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001557","descriptor_name":"Benzenesulfonates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D004195","descriptor_name":"Disease Models, Animal","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004791","descriptor_name":"Enzyme Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007211","descriptor_name":"Indoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008807","descriptor_name":"Mice, Inbred BALB C","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008810","descriptor_name":"Mice, Inbred C57BL","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008819","descriptor_name":"Mice, Nude","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009362","descriptor_name":"Neoplasm Metastasis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009389","descriptor_name":"Neovascularization, Pathologic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009536","descriptor_name":"Niacinamide","qualifier_ui":"Q000031","qualifier_name":"analogs & derivatives","is_major_topic":false},{"descriptor_ui":"D010671","descriptor_name":"Phenylurea Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011725","descriptor_name":"Pyridines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011758","descriptor_name":"Pyrroles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000145","qualifier_name":"classification","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D040262","descriptor_name":"Receptors, Vascular Endothelial Growth Factor","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D040262","descriptor_name":"Receptors, Vascular Endothelial Growth Factor","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D042461","descriptor_name":"Vascular Endothelial Growth Factor A","qualifier_ui":"Q000276","qualifier_name":"immunology","is_major_topic":false},{"descriptor_ui":"D045744","descriptor_name":"Cell Line, Tumor","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D066298","descriptor_name":"In Vitro Techniques","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1002/path.4052","doi":"https://doi.org/10.1002/path.4052","is_oa":false,"landing_page_url":"https://doi.org/10.1002/path.4052","pdf_url":null,"source":{"id":"https://openalex.org/S4394736614","display_name":"The Journal of Pathology","issn_l":"0022-3417","issn":["0022-3417","1096-9896"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Pathology","raw_type":"journal-article"},{"id":"pmid:22611017","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22611017","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of pathology","raw_type":"Comparative Study"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":49,"referenced_works":["https://openalex.org/W56534538","https://openalex.org/W1503371439","https://openalex.org/W1562355542","https://openalex.org/W1604140953","https://openalex.org/W1967600348","https://openalex.org/W1978340181","https://openalex.org/W1982402091","https://openalex.org/W1993817589","https://openalex.org/W1997533142","https://openalex.org/W2007407831","https://openalex.org/W2011416603","https://openalex.org/W2016569548","https://openalex.org/W2017830994","https://openalex.org/W2021268612","https://openalex.org/W2025391287","https://openalex.org/W2034394424","https://openalex.org/W2036751011","https://openalex.org/W2039013742","https://openalex.org/W2040593473","https://openalex.org/W2057006907","https://openalex.org/W2057711788","https://openalex.org/W2059958205","https://openalex.org/W2064315259","https://openalex.org/W2068562114","https://openalex.org/W2077129920","https://openalex.org/W2080196370","https://openalex.org/W2082320957","https://openalex.org/W2091774189","https://openalex.org/W2100772783","https://openalex.org/W2103430398","https://openalex.org/W2113122060","https://openalex.org/W2113145680","https://openalex.org/W2114444869","https://openalex.org/W2121432337","https://openalex.org/W2123114887","https://openalex.org/W2125857654","https://openalex.org/W2128668160","https://openalex.org/W2135947389","https://openalex.org/W2139731402","https://openalex.org/W2140088548","https://openalex.org/W2143852804","https://openalex.org/W2144718958","https://openalex.org/W2146530991","https://openalex.org/W2146706439","https://openalex.org/W2158965678","https://openalex.org/W2165906785","https://openalex.org/W2168202400","https://openalex.org/W2171085327","https://openalex.org/W2187768968"],"related_works":["https://openalex.org/W2059958205","https://openalex.org/W2058693669","https://openalex.org/W2016569548","https://openalex.org/W1967600348","https://openalex.org/W2488892632","https://openalex.org/W2334157622","https://openalex.org/W2056859838","https://openalex.org/W2329632577","https://openalex.org/W2140088548","https://openalex.org/W2169691707"],"abstract_inverted_index":{"Inhibiting":[0],"angiogenesis":[1],"has":[2,60],"become":[3],"an":[4],"important":[5,181],"therapeutic":[6],"strategy":[7],"for":[8,19,36,182,224,235],"cancer":[9],"treatment":[10],"but,":[11],"like":[12],"other":[13],"current":[14],"targeted":[15],"therapies,":[16],"benefits":[17],"experienced":[18],"late-stage":[20],"cancers":[21],"can":[22,70,209],"be":[23],"curtailed":[24],"by":[25,29],"inherent":[26],"refractoriness":[27],"or":[28],"acquired":[30],"drug":[31,134,213],"resistance,":[32],"requiring":[33],"a":[34,138,172,194],"need":[35],"better":[37],"mechanistic":[38],"understanding":[39],"of":[40,86,108,116,175,197,205,228,230],"such":[41],"effects.":[42],"Numerous":[43],"preclinical":[44],"studies":[45],"have":[46,210],"demonstrated":[47],"that":[48,64,113],"VEGF":[49,66,117,200,207],"pathway":[50,118,208],"inhibitors":[51,96,131,204],"suppress":[52],"primary":[53],"tumour":[54,73,155],"growth":[55],"and":[56,67,75,89,153,170,212,234],"metastasis.":[57,109],"However,":[58],"it":[59],"been":[61],"recently":[62],"reported":[63],"short-term":[65,102],"VEGFR":[68],"inhibition":[69,115,174],"paradoxically":[71],"accelerate":[72],"invasiveness":[74],"metastasis":[76],"in":[77,104,124,168],"certain":[78],"models.":[79],"Here":[80],"we":[81],"comprehensively":[82],"compare":[83],"the":[84,98,199,206,217,225],"effects":[85],"both":[87],"antibody":[88,114],"small":[90,128],"molecule":[91,129],"receptor":[92],"tyrosine":[93,177],"kinase":[94],"(RTK)":[95],"targeting":[97],"VEGF-VEGFR":[99],"pathway,":[100,202],"using":[101],"therapy":[103,236],"various":[105],"mouse":[106],"models":[107],"Our":[110],"findings":[111,189,221],"demonstrate":[112],"molecules":[119,180],"does":[120],"not":[121,161],"promote":[122],"metastasis,":[123,147],"contrast":[125],"to":[126,232,238],"selected":[127],"RTK":[130,140],"at":[132],"elevated-therapeutic":[133],"dosages.":[135],"In":[136],"particular,":[137],"multi-targeted":[139],"inhibitor,":[141],"sunitinib,":[142,159],"which":[143],"most":[144],"profoundly":[145],"potentiated":[146],"also":[148,222],"increased":[149],"lung":[150],"vascular":[151],"permeability":[152],"promoted":[154],"cell":[156],"extravasation.":[157],"Mechanistically,":[158],"but":[160],"anti-VEGF":[162],"treatment,":[163],"attenuated":[164],"endothelial":[165,184],"barrier":[166],"function":[167],"culture":[169],"caused":[171],"global":[173],"protein":[176],"phosphorylation,":[178],"including":[179],"maintaining":[183],"cell-cell":[185],"junctions.":[186],"Together":[187],"these":[188],"indicate":[190],"that,":[191],"rather":[192],"than":[193],"specific":[195],"consequence":[196],"inhibiting":[198],"signalling":[201],"pharmacological":[203],"dose-":[211],"class-dependent":[214],"side-effects":[215],"on":[216],"host":[218],"vasculature.":[219],"These":[220],"advocate":[223],"continued":[226],"identification":[227],"mechanisms":[229],"resistance":[231],"anti-angiogenics":[233],"development":[237],"overcome":[239],"it.":[240]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2011765548","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":6},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":4},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":9},{"year":2014,"cited_by_count":14},{"year":2013,"cited_by_count":20},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-20T13:11:24.684918","created_date":"2016-06-24T00:00:00"}
